Basic Information
ID: ALA4621278
Type: Binding
Description: Inhibition of pseudotyped HIV/EBOV GP infected in human A549 cells assessed as reduction in virus entry at 12.5 uM measured after 48 hrs by luciferase reporter gene assay relative to control
Organism: Ebolavirus
Cell type: A549
Activity Charts
Bioactivity
Activity Types for Assay ALA4621278
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 354.41 | 2.56 | 2.56 |
| 319.41 | 3.80 | 3.80 |
| 390.57 | 6.02 | 6.02 |
| 362.39 | 4.94 | 4.94 |
| 428.91 | 6.19 | 6.19 |
| 401.55 | 5.72 | 5.72 |
| 368.42 | 5.01 | 5.01 |
| 386.54 | 4.04 | 4.04 |
| 346.47 | 4.36 | 4.36 |
| 354.88 | 4.53 | 4.53 |
| 387.50 | 3.30 | 3.30 |
| 358.53 | 4.31 | 4.31 |
| 363.38 | 4.34 | 4.34 |
| 461.53 | 5.03 | 5.03 |
| 362.39 | 4.94 | 4.94 |
| 367.45 | 2.47 | 2.47 |
| 338.41 | 3.62 | 3.62 |
| 394.53 | 6.11 | 6.11 |
| 390.57 | 5.73 | 5.73 |
| 406.61 | 6.52 | 6.52 |
| 352.43 | 3.71 | 3.71 |
| 366.42 | 3.35 | 3.35 |
| 348.49 | 4.61 | 4.61 |
| 392.50 | 4.05 | 4.05 |
| 376.54 | 5.97 | 5.97 |
| 372.49 | 3.33 | 3.33 |
| 378.47 | 3.66 | 3.66 |
| 334.46 | 4.80 | 4.80 |
| 428.62 | 6.39 | 6.39 |
| 396.84 | 5.60 | 5.60 |
| 352.43 | 3.71 | 3.71 |
| 384.50 | 3.72 | 3.72 |
| 388.43 | 4.89 | 4.89 |
| 387.50 | 2.83 | 2.83 |
| 328.50 | 4.37 | 4.37 |
| 350.45 | 4.23 | 4.23 |
| 390.57 | 6.53 | 6.53 |
| 402.46 | 5.46 | 5.46 |
| 358.46 | 3.77 | 3.77 |
| 336.48 | 5.05 | 5.05 |
| 386.42 | 5.33 | 5.33 |
| 388.43 | 4.89 | 4.89 |
| 430.59 | 5.24 | 5.24 |
| 338.43 | 4.01 | 4.01 |
| 352.43 | 3.71 | 3.71 |
| 413.51 | 5.16 | 5.16 |
| 396.84 | 5.60 | 5.60 |